WeedLife News Network

Although flower still reigns king in the world of cannabis, edibles are quickly catching pace as one of the most in-demand products on the market today, making up roughly 23% of total sales in 2020. This statistic holds true in both legal and illegal areas. As a matter of fact, in my own experience I have found that edibles are even more popular in states with strict cannabis regulations, where variety and more modern products like concentrates are much harder to find.

Oregon’s Marijuana Market Continues To Grow Even During Covid-19

The state of Oregon has sustained a solid market for legal cannabis sales. Especially in the last year while in the middle of a worldwide pandemic. Projections for Oregon’s cannabis market are anticipated to grow even more.

Which could lead to more cannabis revenue that can then be used for the state. For instance things like rebuilding communities impacted by the war on drugs or social equity. Analysts with the state Department of Administrative Services’ Office of Economic Analysis shared their thoughts.

Indoor cultivation of cannabis is responsible for about 10% of all industrial electricity consumption in Massachusetts, a representative from the Northeast Sustainable Cannabis Project estimated Tuesday as he called on lawmakers to allow marijuana and hemp growers to use organic farming practices that could shift some of the cultivation outside and under the sun.

If you want to earn some extra dough, now may be the ideal time to invest in cannabis. And no, we don’t mean buying edibles in bulk.

2020 was a record year for cannabis. According to Leafly, the legal industry saw over $18 billion in sales – a 71% increase from the year prior.

Hemp and substances derived from hemp now approved for use in commercial feed for pets, specialty pets, and horses in Montana

As established in House Bill 396 signed during the 2021 legislative session, hemp and substances derived from hemp are now approved for use in commercial feed for pets, specialty pets, and horses in Montana, so long as they do not contain more than 0.3% tetrahydrocannabinol, or THC.

The Massachusetts Cannabis Control Commission on Friday announced that equity applicants can officially apply for a license type that will allow for cannabis to be warehoused and then sold and delivered.

The marijuana delivery operator license type is only available to economic empowerment and social equity applicants for a minimum of three years. As of Friday, qualified applicants can apply for pre-certification and for the license. The exclusivity period begins the date the first company with the license type receives a notice to commence operations, the cannabis agency said in a statement.

There are dozens of good reasons for legalizing cannabis, and one of the most compelling is its potential for social justice.

For the most part, cannabis criminalization occurred throughout the 20th century as a result of xenophobia and racism; white Americans of European descent were frightened by increasing numbers of immigrants from Asia and Latin America, many of whom used cannabis products recreationally and for cultural or spiritual expression.

By controlling cannabis, states and the Federal Government gained greater control over these marginalized groups.

Cannabis Stocks And 2021 Market Performance

As leading marijuana stocks appear to bounce back in the market which pot stocks are you investing in? In 2021 top cannabis stocks to buy have taken investors on a ride of market volatility that has left some investors down in the sector. After reaching new highs in February most pot stocks have seen a sharp decline in value for the past few months.

Cannabis stores are one of the fastest growing industries, and self-order technology is playing an important role in this emerging sector, currently valued at more than $18 billion, according to Leafly, a cannabis industry information resrouce, supporting the equivalent of over 300,000 full-time jobs.

A total of 17 states currently have legal adult use, as shown on the accompanying chart. More states are expected to legalize adult use, given the fact that polls show strong public support for it.

A story equally impressive may be in its overseas activities.

2021 is looking to be the year in which we find some normalcy and recovery. For Curaleaf Holdings (OTC:CURLF), a vertically integrated cannabis producer, 2021 has so far been nothing short of record-breaking. The company recently reached a milestone $1 billion in annual sales, hitting $260 million in the first quarter of this year. 

Lawmakers in Uruguay made history by passing an adult-use legalization measure that was signed into law in late 2013.

Uruguay will forever be known as the first country on earth to legalize cannabis for adult use, as well as the first country to allow legal adult-use cannabis sales.

Only one other country, Canada (2018), has legalized cannabis for adult use.

Uruguay’s legalization model differs quite a bit from Canada, with one of the biggest differences being who can legally purchase cannabis.

As the Founder and CEO of Humboldt Seed Company, I have been breeding cannabis for more than 20 years. I've seen many trends in the craft cannabis space. Here's what I see on the harvest horizon. 

New York’s effort to legalize recreational marijuana for adult use took three years to accomplish and resulted in a 128-page, 7,000-line law that will require more than a year to fully take effect.

Let’s just say it’s complex. But the most fundamental thing to know is that it’s now legal for those 21 and over to possess up to three ounces of marijuana for personal use.

Oregon regulators pulled marijuana vape products off retailers’ shelves because they allegedly contained cannabis-derived terpenes imported from California. The Oregon Liquor Control Commission (OLCC), which regulates the state’s licensed recreational marijuana market, issued a health and safety recall for marijuana vaping products sold under the “Naked Extracts” and “Native” labels.

Do You Have These Top Marijuana Stocks On Your Watchlist In May?

In recent trading, many marijuana stocks have started to build more market momentum. This current upward push for most cannabis stocks has been long overdue after coming off a 3-month downtrend. Yet during this downtrend, all was not lost for the cannabis industry and investors. For one when cannabis stocks were trading at lower share prices, this created a big buying opportunity. Next was many leading cannabis companies were able to further expand and grow their business.

17 states have legalized adult-use cannabis, though most continue to prohibit consumption in public or rented spaces.

For years, cannabis consumption lounges have been kept at bay, though lately pro-lounge legislation is becoming more prevalent in the legal cannabis marketplace.

The cannabis industry is nothing if not creative about regulatory loopholes along the way to financing. The entire vertical, in fact, has been built just about everywhere in the grey edges of the law. Companies who have raised cash through cannabis fundraising so far have literally paved the way for the industry itself—but the route if not the means has been just as tenuous. If not frequently outright ludicrous. This has been less than remunerative for many early investors in the market. First mover “advantage” in this industry is certainly not all it’s cracked up to be…and is often unbelievably expensive.

The Drug Enforcement Administration made a milestone announcement earlier this month with the news that the DEA will begin granting marijuana cultivation licenses to various third-party applicants, significantly expanding medical and scientific cannabis research in the United States.

The announcement came on May 14, with the Administration saying it “is nearing the end of its review of certain marijuana grower applications, thereby allowing it to soon register additional entities authorized to produce marijuana for research purposes.”

Delta-8 THC and New York are two topics that have been making headlines in the cannabis world lately. Delta-8 has been reported upon for being a controversial compound that is legal through a loophole, and New York has been in the news for making recreational cannabis legal. Now, the two are making headlines again, this time together, because New York has banned Delta-8 THC. 

Patient-first biotech company Enveric Biosciences (NASDAQ: ENVB) is buying MagicMed Industries Inc., a privately-held biotechnology company focused on creating a library of novel derivative psychedelic molecules such as psilocybin, N,N-dimethyltryptamine (DMT) and other molecular derivatives with applications across multiple indications, in an all-stock transaction. The deal has an approximate value of $30 million.